Zero ad trackers.We never sell your data.

Home / For clinicians / Conditions

Conditions, by specialty

16 conditions so far. Each page compares the approved drugs and lists FDA decisions, label changes and open trials.

By specialty and condition

Each condition page compares its drugs side by side and lists FDA decisions, label changes and open trials. Know the drug already? Use the prescribing guides A to Z.

Cardiology
Compare the drugs →
Amvuttra vutrisiranAttruby acoramidisVyndamax tafamidis
Compare the drugs →
Camzyos mavacamtenMyqorzo aficamten
Endocrinology
Acromegaly
3 prescribing guides · 1 FDA decision pending
Compare the drugs →
Palsonify paltusotineSandostatin LAR Depot octreotideSomatuline Depot lanreotide
Hematology
Hemophilia A
2 prescribing guides · 1 FDA decision pending
Compare the drugs →
Altuviiio antihemophilicHemlibra emicizumab-kxwh
Compare the drugs →
Wayrilz rilzabrutinib
Compare the drugs →
Empaveli pegcetacoplan
Medical genetics
Fabry disease
3 prescribing guides · 1 FDA decision pending
Compare the drugs →
Elfabrio pegunigalsidaseFabrazyme agalsidaseGalafold migalastat
Gaucher disease
1 prescribing guide · 1 FDA decision pending
Compare the drugs →
Cerezyme imiglucerase
Nephrology
IgA nephropathy
7 prescribing guides · 1 FDA decision pending
Compare the drugs →
Fabhalta iptacopanFilspari sparsentanTarpeyo budesonideTrutakna ataciceptUltomiris ravulizumab-cwvzVanrafia atrasentanVoyxact sibeprenlimab
Neurology
ALS with a SOD1 mutation
1 prescribing guide
Compare the drugs →
Qalsody tofersen
Generalized myasthenia gravis
4 prescribing guides · 2 FDA decisions pending
Compare the drugs →
Imaavy nipocalimab-aahuRystiggo rozanolixizumab-noliVyvgart efgartigimodZilbrysq zilucoplan
Compare the drugs →
Enspryng satralizumab-mwgeUplizna inebilizumab-cdon
Relapsing multiple sclerosis (MS)
1 prescribing guide · 1 FDA decision pending
Compare the drugs →
Kesimpta ofatumumab
Other specialties
Compare the drugs →
Atebrioz zilurgisertibSohonos palovarotene
Primary biliary cholangitis (PBC)
1 prescribing guide · 1 FDA decision pending
Compare the drugs →
Livdelzi seladelpar
Sanfilippo syndrome type A
1 prescribing guide
Compare the drugs →
Fayuvi rebisufligene